Tonymoly Co., Ltd (KRX:214420)
South Korea
· Delayed Price · Currency is KRW 6,460.00
-510.00 (-7.32%)
Mar 9, 2026, 3:30 PM KST
Tonymoly Revenue
Tonymoly had revenue of 56.29B KRW in the quarter ending September 30, 2025, with 25.19% growth. This brings the company's revenue in the last twelve months to 210.86B, up 16.72% year-over-year. In the year 2024, Tonymoly had annual revenue of 177.00B with 17.14% growth.
Revenue (ttm)
210.86B
Revenue Growth
+16.72%
P/S Ratio
0.73
Revenue / Employee
1.85B
Employees
114
Market Cap
154.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 177.00B | 25.90B | 17.14% |
| Dec 31, 2023 | 151.09B | 24.35B | 19.21% |
| Dec 31, 2022 | 126.75B | 12.10B | 10.55% |
| Dec 31, 2021 | 114.65B | 1.19B | 1.05% |
| Dec 31, 2020 | 113.46B | -58.57B | -34.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hankook Cosmetics Manufacturing | 28.82B |
| Cha AI Healthcare | 7.84B |
| It'S Hanbul | 152.29B |
| Hankook Cosmetics | 90.11B |
| Able C&C | 256.01B |
| NeoPharm CO., LTD. | 129.81B |
| Kolmar Holdings | 650.73B |
| KOLMAR BNH | 594.71B |